Live Breaking News & Updates on Vincent Capponi

Stay updated with breaking news from Vincent capponi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cytosorbents Corporation (NASDAQ:CTSO) Q1 2024 Earnings Call Transcript

Cytosorbents Corporation (NASDAQ:CTSO) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United States , Christian Steiner , Makis Deliargyris , Michael Mack , Vincent Capponi , Eric Ribner , Phillip Chan , Phil Chan , Kathleen Bloch , Christopher Cramer , Health Canada , Cytosorbents Corp , Cytosorbents Corporation , Business Development , Call Transcript May , Cytosorbent First Quarter , Operating Results Conference , Chief Executive Officer , Chief Operating Officer , Chief Financial Officer , Chief Medical Officer , Executive Vice President , Senior Vice President , Safe Harbor , Private Securities Litigation Reform Act , Expensive Lipsticks ,

CytoSorbents Reports Third Quarter 2023 Financial and Operational Results

PRINCETON, N.J., Nov. 09, 2023 (GLOBE NEWSWIRE) CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood ....

New Jersey , United States , State Of New Jersey , New York , Kathleen Bloch , James Komsa , Irina Kulinets , Vincent Capponi , Phillip Chan , Efthymios Deliargyris , National Institutes Of Health , National Heart , Fresenius Medical Care , Human Services , Material Command , Bus Company Contact , Us Army , Cytosorbents Corporation , Vascular Group , Development Expenses , European Union , Us Department Of Health , Blood Institute , Us Centers Of Medicare Medicaid Services , Company Board Of Directors , Us Air ,

CytoSorbents Reports Third Quarter 2023 Financial and Operational Results

Q3 2023 Product sales grew 20% to $7.8M versus $6.5M in Q3 2022. Q3 2023 Total revenue was approximately $8.8M. The pivotal STAR-T trial remains blinded with database lock nearing and initial data analysis completion expected before year-end.PRINCETON, N.J., Nov. 09, 2023 (GLOBE NEWSWIRE) CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorptio ....

State Of New Jersey , New Jersey , United States , New York , Kathleen Bloch , Vincent Capponi , James Komsa , Phillip Chan , Irina Kulinets , Efthymios Deliargyris , Health Canada , National Heart , Bus Company Contact , Development Expenses , Us Centers Of Medicare Medicaid Services , National Institutes Of Health , Human Services , Cytosorbents Corporation , Blood Institute , Material Command , Us Department Of Health , European Union , Us Army , Us Air , Vascular Group , Fresenius Medical Care ,

Cytosorbents Corporation (NASDAQ:CTSO) Q4 2022 Earnings Call Transcript

Operator: Good afternoon, and welcome to the Cytosorbents Fourth Quarter and Full Year 2022 Financial and Operating Results Conference Call. At this time, all participants are in a listen-only mode. ....

United States , France General , Noord Holland , Richard Whitlock , Christopher Cramer , Josh Jennings , Irina Kulinets , Michael Gibson , Efthymios Deliargyris , Vincent Capponi , Kathleen Bloch , Cytosorbents Europe Gmb , Christian Steiner , Mike Sarcone , Vince Capponi , Michael Mack , Jodi Hoover , Phillip Chan , Regulatory Affairs For Microvention , Cytosorbents Corp , European Society Of Anaesthesiology , European Association Of Cardiothoracic Surgery , European Society Of Cardiology , European Union , Canadian Research , Cytosorbents Corporation ,

CytoSorbents Appoints Irina B. Kulinets, PhD, as Senior Vice President of Global Regulatory Affairs

/PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac. ....

United States , South Korea , Georgetown University , District Of Columbia , Northeastern University , Irina Kulinets , Irinab Kulinets , Vincent Capponi , Kathleen Bloch , Material Command , Clinical Research , Cytosorbents Corporation , Regulatory Affairs Professionals Society , Anika Therapeutics , Regulatory Affairs , National Institutes Of Health , Health Science , Product Service , Quality At Microvention Inc , Board Certified In Medical Affairs , Belarus Polytechnic Academy , Regulatory Affairs Certification , Terumo Corporation , European Union , Us Army , National Heart ,